Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2014 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference

NEW YORK, June 5, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Greg Madison, the Company's Chief Operating Officer, will present a corporate overview at...
May 22, 2014 16:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM)

NEW YORK, May 22, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced today that the U.S. Food and Drug Administration (FDA) has extended the initial...
May 08, 2014 07:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results

NEW YORK, May 8, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients suffering from renal...
May 06, 2014 08:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Opening of Boston Office

NEW YORK and BOSTON, May 6, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients suffering...
May 05, 2014 16:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2014 Financial Results

NEW YORK, May 5, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients suffering from renal...
April 15, 2014 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal

NEW YORK, April 15, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical...
April 09, 2014 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2014 Spring Clinical Meeting

NEW YORK, April 9, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced that Phase 2 clinical results of Zerenex™ (ferric citrate coordination...
April 02, 2014 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM)

NEW YORK, April 2, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced that the European Medicines Agency ("EMA") has determined that the Company's...
March 17, 2014 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo

NEW YORK, March 17, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that data highlighting the potential pharmacoeconomic benefit of Zerenex™ (ferric...
March 12, 2014 16:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results

NEW YORK, March 12, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical...